Cytek Biosciences Inc (CTKB)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 200,453 | 193,015 | 164,036 | 127,950 | 92,839 |
| Total assets | US$ in thousands | 499,500 | 494,457 | 519,476 | 463,700 | 219,979 |
| Total asset turnover | 0.40 | 0.39 | 0.32 | 0.28 | 0.42 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $200,453K ÷ $499,500K
= 0.40
Total asset turnover is a financial ratio that measures a company's efficiency in generating sales revenue from its total assets. In the case of Cytek Biosciences Inc, the total asset turnover has fluctuated over the years as follows:
- December 31, 2020: 0.42
- December 31, 2021: 0.28
- December 31, 2022: 0.32
- December 31, 2023: 0.39
- December 31, 2024: 0.40
The decreasing trend from 2020 to 2021 indicates that the company may have become less efficient in utilizing its assets to generate sales. However, there was a slight improvement in 2022, followed by further increases in 2023 and 2024.
Overall, the total asset turnover ratio for Cytek Biosciences Inc has shown some variability, which suggests that the company's ability to generate sales from its total assets has been mixed over the years. It would be important to further investigate the underlying reasons for these fluctuations to determine the company's operational efficiency and financial performance.
Peer comparison
Dec 31, 2024